Get the Stockscreener App
18.69
2.20%
-0.42
After Hours:
18.70
0.010
+0.05%
Liquidia Corp stock is traded at $18.69, with a volume of 1.68M.
It is down -2.20% in the last 24 hours and up +50.00% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$19.11
Open:
$19.05
24h Volume:
1.68M
Relative Volume:
0.72
Market Cap:
$1.60B
Revenue:
$17.49M
Net Income/Loss:
$-78.50M
P/E Ratio:
-15.58
EPS:
-1.2
Net Cash Flow:
$-52.85M
1W Performance:
-0.43%
1M Performance:
+50.00%
6M Performance:
+31.34%
1Y Performance:
+56.66%
1-Day Range:
$18.31
$19.34
1-Week Range:
$18.31
$20.33
52-Week Range:
$8.26
$20.33
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
18.69 | 1.63B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
BTIG Lowers Liquidia (LQDA) PT to $40, Potential for Yutrepia Launch Remains a Focus - Insider Monkey
Will Liquidia Corporation bounce back from current supportWeekly Return Plan for Conservative Traders - Newser
What makes Liquidia Corporation stock price move sharplyMarket Forecast Insights For 2025 - jammulinksnews.com
Is Liquidia Corporation stock poised for growthFree Swing Trading Plan With Smart Signals - Newser
Quantitative breakdown of Liquidia Corporation recent moveFree Trade Scanner With Buy Zone Alerts - Newser
How Liquidia Corporation stock performs during market volatilityHigh Confidence Strategy with Trend Alignment - Newser
Drawdown in Liquidia Corporation May Be Nearing EndSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Liquidia Corporation Recovery Gathers Momentum on Chart SignalsAlpha Driven Watchlist With Alerts Published - metal.it
Sector ETF Data Correlates with Strength in Liquidia CorporationOptimized Watchlist With Daily Adjustments Launched - metal.it
Liquidia's Stock Jumps, But Analyst Skepticism Remains - Finimize
Bleecker Street Research short United Therapeutics, long Liquidia - TipRanks
RSI + MACD Show Convergence for Liquidia CorporationMarket Entry and Exit Point Tips From Traders - metal.it
Fibonacci Levels Suggest Recovery for Liquidia CorporationDaily Momentum Screener With Alerts Launched - metal.it
What are Liquidia Corporation company’s key revenue driversChart Pattern Updates For Fast Growth - jammulinksnews.com
Why is Liquidia Corporation stock attracting strong analyst attentionFree Stock Chart Pattern Guide - jammulinksnews.com
Can volume confirm reversal in Liquidia CorporationPrice Movement and Market Sentiment Analysis - Newser
How many analysts rate Liquidia Corporation as a “Buy”Build a portfolio with strong long-term growth - jammulinksnews.com
Liquidia Corporation Earnings Report Breakdown: What Investors Should KnowBreakout Momentum Stocks - metal.it
What catalysts could drive Liquidia Corporation stock higher in 2025Spectacular growth rates - jammulinksnews.com
Why Liquidia Corporation stock attracts strong analyst attentionFree Capital Allocation Plans - Newser
Liquidia Technologies stock hits 52-week high at 19.46 USD - Investing.com
Arquitos Capital Management Q2 2025 Investor Letter - Seeking Alpha
Can Liquidia Corporation stock recover from recent declineLightning-fast capital gains - jammulinksnews.com
What analysts say about Liquidia Corporation stockSuperior investment outcomes - jammulinksnews.com
Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling - MSN
Liquidia Corporation Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com
Does Liquidia Corporation stock pay reliable dividendsTargeted 200 Percent Gain - Newser
Liquidia Corp: chief human resource officer Krepp sells $38k in stock - Investing.com India
Liquidia Corp: chief human resource officer Krepp sells $38k in stock By Investing.com - Investing.com South Africa
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
When Can We Expect A Profit From Liquidia Corporation (NASDAQ:LQDA)? - simplywall.st
Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo Finance
Liquidia Signs 70,000 SF Life Sciences Lease at Pathway Triangle in Morrisville, North Carolina - REBusinessOnline
DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC FilingForm 3 - Stock Titan
Liquidia Technologies Appoints Dana Boyle as Chief Accounting Officer - The Globe and Mail
Liquidia appoints Dana Boyle as chief accounting officer - Investing.com
What Next For Liquidia After Launch? (NASDAQ:LQDA) - Seeking Alpha
BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ - GuruFocus
BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQDA Stock News - GuruFocus
Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac - GuruFocus
Liquidia Attacks UTC’s Tyvaso Drug Patent at Bench Trial Opening - Bloomberg Law News
Liquidia Corporation Secures Additional $50 Million to Support YUTREPIA™ Launch Following Legal Victory - Nasdaq
Billion-dollar life sciences campus finally signs first tenant - The Business Journals
Liquidia leases space for manufacturing facility near headquarters - Business North Carolina
Liquidia Technologies Holds Annual Stockholders Meeting - TipRanks
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):